Mayo Clinic Announces Collaboration to Develop Diagnostic for Lung Cancer
The tests will use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases.
Read More
Search Results for: lung cancer
January 2019 Product Spotlight: 2019 Emerging Technologies Showcase
Nano-Signature Discovery Could Revolutionize Cancer Diagnosis A quick and easy test to...
Read More
Kanazawa University Research Reveals Origin of Lung Cancer Drug Resistance
The findings demonstrated what causes some lung cancer patients to have an intrinsic resistance to the drug osimertinib.
Read More
Multivariate Blood Test Can Predict Outcomes for Non-Small Cell Lung Cancer
Individuals identified with VeriStrat poor results had significantly lower overall survival when treated with immune checkpoint inhibitor-based regimens.
Read More
FDA Approves Companion Diagnostic for Triple-Negative Breast Cancer
The assay is the first companion diagnostic approved for identifying triple-negative breast cancer patients who are eligible for PD-L1 immunotherapy.
Read More